StmaA.00156.a
Threonyl-tRNA synthetase (EC 6.1.1.3) (thrS)
CENTER ID:
StmaA.00156.a
ORGANISM:
Stenotrophomonas maltophilia K279a
ASSOCIATED DISEASE:
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
False
NIH RISK GROUP:
Emerging
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
non-BEI
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
StmaA.00156.a.B1.GE43198
Full length(StmaA.00156.a)
info
1
633
StmaA.00156.a.B1.GE43198
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
StmaA.00156.a.B1.PW38695
Full length(StmaA.00156.a)
info
1
633
PW38695
Structures
6VU9
DEPOSITED: 2/14/2020
DETERMINATION: XRay
CLONE: StmaA.00156.a.B1.GE43198
PROTEIN: StmaA.00156.a.B1.PW38695
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MINITLPDGS RREFENPVSV MEVAQSIGAG LAKATIAGAV DGVLVDASDV IDHDASLRII TAKDEEGVEI IRHSCAHLVG HAVKQLYPDV KMVIGPVIAE GFYYDIYSER PFTPDDMAAI EKRMGELIAQ DYDVIKKMTP RAEVIEIFKA RGEDYKLRLI EDMSEDIQAM GMYYHQEYVD MCRGPHVPNT RFLKAFKLTR ISGAYWRGDA QNEQLQRIYG TAWADKKQLE AYIKRIEEAE MRDHRRIGKQ QDLFHLQEEA PGLVFWHPKG WALWQVVEQY MRKVYRNSGY GEVRCPQILD VSLWKKSGHW DNYQDNMFFT ESEKRTYAVK PMNCPGHIQV FNQGLHSYRD LPIRYGEFGS CHRNEPSGAL HGILRVRGFT QDDGHVFCTE NQIESEVTAF HQQALAVYQH FGFDEIQIKI ALRPESRLGD DATWDKAEGA LRSALTACGV EWQELPGEGA FYGPKIEYHL KDAIGRTWQL GTMQVDFMMP GRLGAEYVDE NSQKKHPVML HRAIVGSMER FLGILIEHHA GQFPAWLAPT QVVVANITDA QADYVSGVTK TLAEQGFRVS SDLRNEKIGY KIREHTLQRV PYLLVIGDRE KENGAVAVRT RSGEDLGSMS LQAFIERLHA EGA
NT Sequence
ATGATCAACA TTACTCTTCC CGACGGCAGC CGCCGCGAAT TTGAAAACCC CGTCAGCGTC ATGGAGGTCG CCCAGTCGAT CGGCGCCGGC CTGGCCAAGG CCACCATCGC CGGTGCCGTG GATGGCGTGC TGGTCGATGC CAGCGACGTC ATCGACCACG ATGCCAGCCT GCGCATCATC ACCGCCAAGG ACGAGGAGGG CGTGGAGATC ATCCGCCACT CCTGCGCCCA CCTGGTCGGC CACGCCGTCA AGCAGCTCTA CCCGGACGTG AAGATGGTGA TCGGCCCGGT GATCGCCGAA GGCTTCTATT ACGACATCTA CTCCGAGCGC CCGTTCACCC CGGACGACAT GGCCGCGATC GAGAAGCGCA TGGGCGAGCT GATCGCCCAG GACTACGACG TCATCAAGAA GATGACCCCG CGCGCCGAAG TGATCGAGAT CTTCAAGGCC CGTGGCGAGG ACTACAAGCT GCGCCTGATC GAGGACATGT CCGAGGACAT CCAGGCGATG GGCATGTACT ACCACCAGGA ATACGTGGAC ATGTGCCGTG GCCCGCACGT GCCGAACACG CGCTTCCTGA AGGCCTTCAA GCTGACCCGC ATCTCCGGCG CCTATTGGCG CGGCGACGCG CAGAACGAGC AGCTGCAGCG CATCTACGGC ACCGCCTGGG CCGACAAGAA GCAGCTCGAG GCGTACATCA AGCGCATCGA AGAAGCTGAA ATGCGCGACC ACCGCCGCAT CGGCAAGCAG CAGGACCTGT TCCACCTGCA GGAAGAAGCA CCGGGCCTGG TGTTCTGGCA CCCGAAGGGC TGGGCGCTGT GGCAGGTGGT CGAGCAGTAC ATGCGCAAGG TCTACCGCAA CAGCGGCTAC GGCGAAGTGC GCTGCCCGCA GATCCTGGAC GTGAGCCTGT GGAAGAAGTC CGGTCACTGG GACAACTACC AGGACAACAT GTTCTTCACC GAATCGGAGA AGCGCACGTA CGCGGTCAAG CCGATGAACT GCCCAGGCCA CATCCAGGTG TTCAACCAGG GCCTGCACAG CTACCGCGAC CTGCCGATCC GCTATGGTGA GTTCGGTTCG TGCCATCGCA ACGAGCCGTC CGGCGCGCTG CACGGCATCC TGCGCGTGCG TGGCTTCACC CAGGACGACG GCCACGTGTT CTGCACGGAA AACCAGATCG AGTCGGAAGT GACGGCCTTC CACCAGCAGG CGCTGGCGGT CTACCAGCAC TTCGGTTTCG ACGAGATCCA GATCAAGATC GCGCTGCGCC CGGAATCGCG CCTGGGTGAC GACGCCACTT GGGACAAGGC CGAAGGCGCG CTGCGCTCGG CGCTGACCGC CTGTGGCGTG GAATGGCAGG AGCTGCCGGG CGAGGGCGCC TTCTACGGCC CGAAGATCGA GTACCACCTG AAGGATGCCA TCGGCCGTAC CTGGCAGCTG GGCACCATGC AGGTGGACTT CATGATGCCG GGCCGCCTGG GCGCCGAGTA CGTGGACGAG AACAGCCAGA AGAAGCACCC GGTCATGCTG CACCGCGCCA TCGTCGGCTC GATGGAGCGC TTCCTGGGCA TCCTGATCGA GCACCATGCC GGCCAGTTCC CGGCTTGGCT GGCGCCGACC CAGGTGGTGG TGGCCAACAT CACCGACGCC CAGGCCGACT ACGTCTCGGG CGTGACCAAA ACCCTTGCGG AGCAAGGCTT CCGCGTCAGC TCGGATTTGC GTAACGAGAA GATCGGCTAT AAAATCCGCG AGCATACGTT GCAGCGCGTG CCCTACCTGC TGGTCATCGG TGACCGCGAG AAGGAAAATG GGGCTGTGGC GGTGCGTACG CGTTCTGGCG AAGACCTGGG CAGCATGAGC CTGCAGGCCT TCATCGAGCG GCTCCACGCC GAGGGCGCG
Details for StmaA.00156.a.B1.GE43198
HARVESTED ON:
5/17/2019
SEQUENCED ON:
5/24/2019
EXPECTED MW:
73kDa
OBSERVED MW:
73kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Good (10-50)
TOTAL EXPRESSION LEVEL:
High Expression
SOLUBLE EXPRESSION LEVEL
High Expression
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for StmaA.00156.a.B1.PW38695
PURIFICATION DATe:
8/29/2019
CONCENTRATION:
30mg/ml
OBSERVED MW:
73kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
5
VIAL VOLUME:
110µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable